Extending IGF-1 Receptor Inhibition Beyond Thyroid Eye Disease: A Scoping Review of Teprotumumab Administration in Pretibial Myxedema

Academic Pediatrics · Elsevier

Аннотация

Publication date: July–August 2026 Source: AACE Endocrinology and Diabetes, Volume 13, Issue 4 Author(s): Maxim John Levy Barnett, Maria Helena Siqueira Tavares de Melo, Maria Luiza de Medeiros Rego

Читать у издателя →

Похожие статьи